Radiopharmaceutical Market by Type, for Cardiology, Neurology, Oncology and Other Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

  • ID: 3978352
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 4

FEATURED COMPANIES

  • Bayer Healthcare
  • Bracco Imaging S.p.A
  • Cardinal Health, Inc.
  • GE Healthcare
  • Nordion, Inc.
  • MORE
Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and Other Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

The report covers forecast and analysis for the radiopharmaceutical market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million) and volume. The study includes drivers and restraints for the radiopharmaceutical along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the radiopharmaceutical market on a global level.

In order to give the users of this report a comprehensive view on the radiopharmaceutical market, we have included a detailed segmentation of radiopharmaceutical. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the radiopharmaceutical market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the radiopharmaceutical market by segmenting the market based on type and application. Diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals are the type segment of Radiopharmaceuticals market. Cardiology, neurology, oncology and other are the key application segment of radiopharmaceutical market. All the application segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.

Some of the major players in the radiopharmaceuticals market include Cardinal Health, Inc., GE Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A., Bayer Healthcare, Lantheus Medical Imaging, Inc., IBA Molecular Imaging, Mallinckrodt plc, Jubilant Pharma, and Siemens Healthcare.

The report segments the global radiopharmaceuticals market as:

Radiopharmaceuticals Market: Type Segment Analysis

- Diagnostic Radiopharmaceuticals

- SPECT
- PET

- Therapeutic radiopharmaceuticals

- Beta emitters
- Alpha emitters
- Brachytherapy isotopes

Radiopharmaceuticals Market: Application Segment Analysis

- Cardiology
- Neurology
- Oncology
- Other

Radiopharmaceuticals Market: Regional Segment Analysis

- North America

- U.S.

- Europe

- UK
- France
- Germany

- Asia Pacific

- China
- Japan
- India

- Latin America

- Brazil

- Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer Healthcare
  • Bracco Imaging S.p.A
  • Cardinal Health, Inc.
  • GE Healthcare
  • Nordion, Inc.
  • MORE
Chapter 1. Preface
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

Chapter 2. Executive Summary
2.1. Global Radiopharmaceutical Market, 2015 - 2021, (USD Billion)
2.2. Radiopharmaceutical : Market snapshot

Chapter 3. Radiopharmaceutical Market: Industry Analysis
3.1. Radiopharmaceutical : Market dynamics
3.2. Value Chain Analysis
3.3. Market Drivers
3.3.1. Growing demand for PET and SPECT radioisotopes
3.3.2. Increasing incidences of cancer and heart diseases
3.4. Restraints
3.4.1. Stringent regulatory guidelines
3.4.2. Shorter half-life of nuclear medicine
3.5. Opportunity
3.5.1. Advancing technologies and ongoing research
3.6. Porter’s Five Forces Analysis
3.7. Market Attractiveness Analysis
3.7.1. Market attractiveness analysis by type segment
3.7.2. Market attractiveness analysis by application segment
3.7.3. Market attractiveness analysis by regional segment

Chapter 4. Global Radiopharmaceutical Market: Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global radiopharmaceutical market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions & Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Product and Regional Expansion
4.3. Price Trend Analysis
4.4. Product Portfolio
4.5. Patent Analysis (2011-2016)
4.5.1. Patent Trend
4.5.2. Patent Share by company
4.5.3. By Region

Chapter 5. Global Radiopharmaceutical Market: Product Overview
5.1. Global radiopharmaceutical market share, by type, 2015 and 2021
5.2. Global diagnostic radiopharmaceutical market, 2015 – 2021 (USD Billion)
5.3. Global therapeutic radiopharmaceutical market, 2015 - 2021 (USD Billion)

Chapter 6. Global Radiopharmaceutical Market: Application Overview
6.1. Global radiopharmaceutical market share, by application, 2015 and 2021
6.2. Global radiopharmaceutical market for cardiology, 2015 - 2021 (USD Billion)
6.3. Global radiopharmaceutical market for neurology, 2015 - 2021 (USD Billion)
6.4. Global radiopharmaceutical market for oncology, 2015 - 2021 (USD Billion)
6.5. Global radiopharmaceutical market for other, 2015 - 2021 (USD Billion)

Chapter 7. Global Radiopharmaceutical Market: Regional Analysis
7.1. Global radiopharmaceutical market: Regional overview
7.1.1. Global radiopharmaceutical market share, by region, 2015 and 2021
7.2. North America
7.2.1. North America radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.2.2. North America radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.2.3.2. U.S. radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.3. Europe
7.3.1. Europe radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.3.2. Europe radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.3.3. UK
7.3.3.1. UK radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.3.3.2. UK radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.3.4. France
7.3.4.1. France radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.3.4.2. France radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.3.5. Germany
7.3.5.1. Germany radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.3.5.2. Germany radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia-Pacific radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.4.2. Asia-Pacific radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.4.3. China
7.4.3.1. China radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.4.3.2. China radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.4.4. Japan
7.4.4.1. Japan radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.4.4.2. Japan radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.4.5. India
7.4.5.1. India radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.4.5.2. India radiopharmaceutical market revenue, by technology, 2015 – 2021 (USD Billion)
7.5. Latin America
7.5.1. Latin America radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.5.2. Latin America radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.5.3.2. Brazil radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
7.6. Middle East & Africa
7.6.1. Middle East & Africa radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
7.6.2. Middle East & Africa radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)

Chapter 8. Company Profiles
8.1. Cardinal Health, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. GE Healthcare
8.2.1. Overview
8.2.2. Financials
8.2.3. Product portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Bracco Imaging S.p.A
8.3.1. Overview
8.3.2. Financials
8.3.3. Product portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Nordion, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Advanced Accelerator Applications S.A.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Bayer Healthcare
8.6.1. Overview
8.6.2. Financials
8.6.3. Product portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. Lantheus Medical Imaging, Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Product portfolio
8.7.4. Business strategy
8.7.5. Recent developments

Chapter 9. Patents
9.1. U.S. (US Patents)
9.2. Europe (EP documents)
9.3. Japan (Abstracts of Japan)
9.4. Global (WIPO (PCT))
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Accelerator Applications S.A.
  • Bayer Healthcare
  • Bracco Imaging S.p.A
  • Cardinal Health, Inc.
  • GE Healthcare
  • Lantheus Medical Imaging, Inc.
  • Nordion, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll